Theis Terwey
Co-founder of GH Research; former Chief Executive Officer
Key Impact
He is a co-founder and longtime leader of GH Research, the company developing GH001 and related psychedelic medicines.
Background & Research
Theis Terwey is a biotechnology executive and co-founder of GH Research in Dublin, Ireland, where he has been involved in the development of inhaled mebufotenin (5-MeO-DMT, GH001) for psychiatric indications. He is listed as an author on multiple GH001 clinical-trial papers, including studies in treatment-resistant depression, postpartum depression, healthy volunteers, and work on the peak experience scale. Public filings and company materials identify him as part of GH Research’s leadership and product-development team.
Collaboration Network
10 collaborators· click a node to visit their profile
Full network →